Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This CarMax Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Author: Avi Kapoor | November 07, 2025 08:53am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Needham analyst Chris Pierce downgraded CarMax, Inc. (NYSE:KMX) from Buy to Hold. CarMax shares closed at $30.88 on Thursday. See how other analysts view this stock.
  • Barclays analyst Gena Wang downgraded Sangamo Therapeutics, Inc. (NASDAQ:SGMO) from Overweight to Equal-Weight and cut the price target from $5 to $1. Sangamo Therapeutics shares closed at $0.4605 on Thursday. See how other analysts view this stock.
  • William Blair analyst Brandon Vazquez downgraded DENTSPLY SIRONA Inc. (NASDAQ:XRAY) from Outperform to Market Perform. Dentsply Sirona shares closed at $11.02 on Thursday. See how other analysts view this stock.
  • UBS analyst Christopher Schoell downgraded Cogent Communications Holdings, Inc. (NASDAQ:CCOI) from Buy to Neutral and cut the price target from $50 to $27. CCOI closed at $24.95 on Thursday. See how other analysts view this stock.
  • Citizens analyst Jordan Bender downgraded Golden Entertainment, Inc. (NASDAQ:GDEN) from Market Outperform to Market Perform. Golden Entertainment shares closed at $28.52 on Thursday. See how other analysts view this stock.

Posted In: CCOI GDEN KMX SGMO XRAY

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist